Randomised phase II trial of docetaxel and sunitinib in patients with metastatic gastric cancer who were previously treated with fluoropyrimidine and platinum
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Randomised phase II trial of docetaxel and sunitinib in patients with metastatic gastric cancer who were previously treated with fluoropyrimidine and platinum
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 106, Issue 9, Pages 1469-1474
Publisher
Springer Nature
Online
2012-03-30
DOI
10.1038/bjc.2012.100
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- (2011) M.J.A. de Jonge et al. EUROPEAN JOURNAL OF CANCER
- An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer
- (2011) M. Moehler et al. EUROPEAN JOURNAL OF CANCER
- Trends of stomach cancer mortality in Eastern Asia in 1950-2004: comparative study of Japan, Hong Kong and Singapore using age, period and cohort analysis
- (2011) Masahiro Tanaka et al. INTERNATIONAL JOURNAL OF CANCER
- Pilot Induction Regimen Incorporating Pharmacokinetically Guided Topotecan for Treatment of Newly Diagnosed High-Risk Neuroblastoma: A Children's Oncology Group Study
- (2011) Julie R. Park et al. JOURNAL OF CLINICAL ONCOLOGY
- Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study
- (2011) Jesus Garcia-Donas et al. LANCET ONCOLOGY
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2008
- (2011) Kyu-Won Jung et al. Cancer Research and Treatment
- Docetaxel plus oxaliplatin (DOCOX) as a second-line treatment after failure of fluoropyrimidine and platinum in Chinese patients with advanced gastric cancer
- (2010) Haijun Zhong et al. ANTI-CANCER DRUGS
- Docetaxel/cisplatin followed by FOLFIRI versus the reverse sequence in metastatic gastric cancer
- (2010) Jung A. Kim et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase II study of sunitinib as second-line treatment for advanced gastric cancer
- (2010) Yung-Jue Bang et al. INVESTIGATIONAL NEW DRUGS
- Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study
- (2009) Francisco Robert et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Docetaxel: its role in current and future treatments for advanced gastric cancer
- (2009) Masahiko Nishiyama et al. Gastric Cancer
- Pharmacogenetic Pathway Analysis for Determination of Sunitinib-Induced Toxicity
- (2009) Nielka P. van Erp et al. JOURNAL OF CLINICAL ONCOLOGY
- Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
- (2009) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now